FIELD: pharmacology.
SUBSTANCE: present invention relates to a compound of Formula (I) or a pharmaceutically acceptable salt thereof, as well as to a specific phenoxymethyl derivative or a pharmaceutically acceptable salt thereof having the ability to inhibit ATC, to a pharmaceutical composition containing them, to their use and to a method for inhibiting ATC
In Formula I, W is selected from ring systems A, B, C, D and E:
wherein RA, RB, RC, RC1, RD1, RD4, A1-A6 are such as defined in the claim.
EFFECT: ATC inhibiting.
38 cl, 30 tbl, 221 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ENZYMES INHIBITION | 2013 |
|
RU2638537C2 |
| ISOQUINOLINONE DERIVATIVES USEFUL IN TREATING CANCER | 2015 |
|
RU2690853C2 |
| TRIAZOLOPYRIDINE JAK INHIBITOR COMPOUNDS AND METHODS | 2009 |
|
RU2561104C2 |
| JAK-INHIBITING TRIAZOLOPYRIDINE COMPOUNDS AND METHODS | 2009 |
|
RU2560153C2 |
| PIPERIDINYLPYRAZOLOPYRIMIDINONES AND USE THEREOF | 2015 |
|
RU2713937C2 |
| HETEROCYCLIC DERIVATIVES AS RECEPTORS ASSOCIATED WITH TRACER AMINES (TAARS) | 2013 |
|
RU2621050C2 |
| PYRIDAZINE DERIVATIVE INHIBITOR, METHOD OF ITS PREPARATION AND ITS USE | 2020 |
|
RU2807611C2 |
| TRIAZOLIUM SALT AS RAR1 INHIBITORS, PREPARING THEM AND USING AS DRUG PREPARATION | 2009 |
|
RU2494100C2 |
| CONDENSED TRIAZOLAMINES AS P2X7 MODULATORS | 2010 |
|
RU2533122C2 |
| PHOSPHODIESTERASE 10 MODULATORS | 2012 |
|
RU2567396C1 |
